Cardiovascular response during severe acute asthma and its treatment in children

Thorax
|July 1, 1981
PubMed

Insights

In children with status asthmaticus, pulsus paradoxus correlated with PaCO2. Combination therapy with aminophylline and salbutamol improved peak expiratory flow more than aminophylline alone.

Area of Science:

  • Pediatric Critical Care
  • Respiratory Medicine
  • Cardiovascular Physiology

Background:

  • Status asthmaticus in children presents significant respiratory and hemodynamic challenges.
  • Transthoracic electrical impedance cardiography (IET) is a non-invasive method to assess hemodynamic parameters.

Purpose of the Study:

  • To evaluate hemodynamic changes and treatment efficacy in children with status asthmaticus.
  • To investigate the correlation between pulsus paradoxus and blood gas levels.
  • To compare the effects of different treatment regimens on respiratory and hemodynamic parameters.

Main Methods:

  • Hemodynamic parameters (heart rate, blood pressure, pulsus paradoxus, cardiac output) were measured using IET in 29 children.
  • Patients received oxygen, intravenous fluids, and hydrocortisone.
  • Patients were randomly assigned to receive aminophylline, salbutamol, or both.
  • Changes were monitored over the first two hours of treatment.

Main Results:

  • Admission pulsus paradoxus correlated significantly with PaCO2 (r=0.66), with values >20 mmHg in patients with PaCO2 >5.5 kPa.
  • Mean stroke volume and cardiac output were 89% and 131% of resting values, respectively.
  • Combination therapy (aminophylline + salbutamol) showed a significantly greater increase in peak expiratory flow (PEF) than aminophylline alone (P<0.05).
  • Nebulized salbutamol was as effective as intravenous salbutamol.
  • Heart rate and systolic blood pressure decreased significantly after nebulized aminophylline and salbutamol, but not with intravenous administration.

Conclusions:

  • Pulsus paradoxus is a useful indicator of hypercapnia in pediatric status asthmaticus.
  • Combination therapy with aminophylline and salbutamol enhances bronchodilation.
  • Hemodynamic parameters did not significantly change with the administered treatments, suggesting relative cardiovascular stability despite severe asthma exacerbation.

Related Concept Videos

Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Adrenergic Antagonists: Pharmacological Actions of &#946;-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...